Elite Pharmaceuticals Inc
ELTP· OTC
Elite Pharmaceuticals Inc
- Close
- Jul 1, 2026
- Market cap
- $387.77M
- 1.08B shares
- Filings
- 1,008
Price
Jul 1, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-03-31 | $148,870,119 | reported | |
| FY 2025 | 2025-03-31 | $84,043,929 | reported | |
| FY 2024 | 2024-03-31 | $56,625,128 | reported | |
| FY 2023 | 2023-03-31 | $34,155,114 | reported | |
| FY 2022 | 2022-03-31 | $32,262,117 | reported | |
| FY 2021 | 2021-03-31 | $25,380,749 | reported | |
| FY 2020 | 2020-03-31 | $17,994,639 | reported | |
| FY 2019 | 2019-03-31 | $7,568,508 | reported | |
| FY 2018 | 2018-03-31 | $7,458,711 | reported | |
| FY 2017 | 2017-03-31 | $9,637,715 | reported | |
| FY 2016 | 2016-03-31 | $12,498,332 | reported | |
| FY 2015 | 2015-03-31 | $5,015,246 | reported |
Elite Pharmaceuticals Inc · CIK 1053369 · Engraved from SEC EDGAR
